These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26010517)

  • 1. Intermittent cardiac overload results in adaptive hypertrophy and provides protection against left ventricular acute pressure overload insult.
    Moreira-Gonçalves D; Henriques-Coelho T; Fonseca H; Ferreira R; Padrão AI; Santa C; Vieira S; Silva AF; Amado F; Leite-Moreira A; Duarte JA
    J Physiol; 2015 Sep; 593(17):3885-97. PubMed ID: 26010517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction.
    Perrino C; Naga Prasad SV; Mao L; Noma T; Yan Z; Kim HS; Smithies O; Rockman HA
    J Clin Invest; 2006 Jun; 116(6):1547-60. PubMed ID: 16741575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of heat shock transcription factor 1 plays a critical role in adaptive cardiac hypertrophy.
    Sakamoto M; Minamino T; Toko H; Kayama Y; Zou Y; Sano M; Takaki E; Aoyagi T; Tojo K; Tajima N; Nakai A; Aburatani H; Komuro I
    Circ Res; 2006 Dec; 99(12):1411-8. PubMed ID: 17095722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tedisamil attenuates foetal transformation of myosin in the hypertrophied rat myocardium.
    Turcani M; Thormaehlen D; Rupp H
    Br J Pharmacol; 2004 Nov; 143(5):561-72. PubMed ID: 15466442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional myosin heavy chain expression in volume and pressure overload induced cardiac hypertrophy.
    Dool JS; Mak AS; Friberg P; Wahlander H; Hawrylechko A; Adams MA
    Acta Physiol Scand; 1995 Dec; 155(4):396-404. PubMed ID: 8719259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular pressure overload during postnatal development. Effects on coronary vasodilator reserve and tolerance to hypothermic global ischemia.
    Yamamoto H; Avkiran M
    J Thorac Cardiovasc Surg; 1993 Jan; 105(1):120-31. PubMed ID: 8419692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Is secondary myocardial hypertrophy a physiological or pathological adaptive mechanism?].
    Krayenbühl HP
    Z Kardiol; 1982 Aug; 71(8):489-96. PubMed ID: 6215776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celecoxib prevents pressure overload-induced cardiac hypertrophy and dysfunction by inhibiting inflammation, apoptosis and oxidative stress.
    Zhang C; Wang F; Zhang Y; Kang Y; Wang H; Si M; Su L; Xin X; Xue F; Hao F; Yu L; Xu J; Liu Y; Xue M
    J Cell Mol Med; 2016 Jan; 20(1):116-27. PubMed ID: 26512452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered cardiac mechanism and sarcoplasmic reticulum function in pressure overload-induced cardiac hypertrophy in rats.
    Ohkusa T; Hisamatsu Y; Yano M; Kobayashi S; Tatsuno H; Saiki Y; Kohno M; Matsuzaki M
    J Mol Cell Cardiol; 1997 Jan; 29(1):45-54. PubMed ID: 9040020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic impact of endurance training and intermittent hypobaric hypoxia on cardiac function and mitochondrial energetic and signaling.
    Magalhães J; Falcão-Pires I; Gonçalves IO; Lumini-Oliveira J; Marques-Aleixo I; Dos Passos E; Rocha-Rodrigues S; Machado NG; Moreira AC; Miranda-Silva D; Moura C; Leite-Moreira AF; Oliveira PJ; Torrella JR; Ascensão A
    Int J Cardiol; 2013 Oct; 168(6):5363-71. PubMed ID: 24012275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload.
    Doenst T; Pytel G; Schrepper A; Amorim P; Färber G; Shingu Y; Mohr FW; Schwarzer M
    Cardiovasc Res; 2010 Jun; 86(3):461-70. PubMed ID: 20035032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise preconditioning attenuates pressure overload-induced pathological cardiac hypertrophy.
    Xu T; Tang H; Zhang B; Cai C; Liu X; Han Q; Zou L
    Int J Clin Exp Pathol; 2015; 8(1):530-40. PubMed ID: 25755743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCN2/CTGF attenuates myocardial hypertrophy and cardiac dysfunction upon chronic pressure-overload.
    Gravning J; Ahmed MS; von Lueder TG; Edvardsen T; Attramadal H
    Int J Cardiol; 2013 Oct; 168(3):2049-56. PubMed ID: 23452880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockout of p21-activated kinase-1 attenuates exercise-induced cardiac remodelling through altered calcineurin signalling.
    Davis RT; Simon JN; Utter M; Mungai P; Alvarez MG; Chowdhury SA; Heydemann A; Ke Y; Wolska BM; Solaro RJ
    Cardiovasc Res; 2015 Dec; 108(3):335-47. PubMed ID: 26464331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload.
    McMullen JR; Sherwood MC; Tarnavski O; Zhang L; Dorfman AL; Shioi T; Izumo S
    Circulation; 2004 Jun; 109(24):3050-5. PubMed ID: 15184287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maturation-dependent differences in regulation of sarcoplasmic reticulum Ca(2+) ATPase in sheep myocardium in response to pressure overload: a possible mechanism for maturation-dependent systolic and diastolic dysfunction.
    Aoyagi T; Fujii AM; Flanagan MF; Arnold L; Mirsky I; Izumo S
    Pediatr Res; 2001 Aug; 50(2):246-53. PubMed ID: 11477211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of beta-myosin heavy chain expression on cardiac function during stress.
    Krenz M; Robbins J
    J Am Coll Cardiol; 2004 Dec; 44(12):2390-7. PubMed ID: 15607403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biphasic response of skeletal muscle mitochondria to chronic cardiac pressure overload - role of respiratory chain complex activity.
    Schrepper A; Schwarzer M; Schöpe M; Amorim PA; Doenst T
    J Mol Cell Cardiol; 2012 Jan; 52(1):125-35. PubMed ID: 22100228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term administration of pyridostigmine attenuates pressure overload-induced cardiac hypertrophy by inhibiting calcineurin signalling.
    Lu Y; Zhao M; Liu JJ; He X; Yu XJ; Liu LZ; Sun L; Chen LN; Zang WJ
    J Cell Mol Med; 2017 Sep; 21(9):2106-2116. PubMed ID: 28296184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KS370G, a synthetic caffeamide derivative, improves left ventricular hypertrophy and function in pressure-overload mice heart.
    Weng YC; Chuang CF; Chuang ST; Chiu HL; Kuo YH; Su MJ
    Eur J Pharmacol; 2012 Jun; 684(1-3):108-15. PubMed ID: 22484506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.